The Gut Microbiome in Anorexia Nervosa: Friend or Foe?

被引:22
|
作者
Ghenciulescu, Ana [1 ]
Park, Rebecca J. [2 ]
Burnet, Philip W. J. [2 ]
机构
[1] Univ Oxford, Med Sci Div, Oxford Med Sch, Oxford, England
[2] Univ Oxford, Dept Psychiat, Oxford, England
来源
FRONTIERS IN PSYCHIATRY | 2021年 / 11卷
关键词
starvation; microbiota; gut-brain axis; metabolites; dysbiosis; treatment; EATING-DISORDERS; METHANOBREVIBACTER-SMITHII; DEPRESSION; AUTOANTIBODIES; METAANALYSIS; BARRIER; ANXIETY; PROTEIN; GENOME;
D O I
10.3389/fpsyt.2020.611677
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The human gut microbiome is emerging as a key modulator of homeostasis, with far-reaching implications for various multifactorial diseases, including anorexia nervosa (AN). Despite significant morbidity and mortality, the underlying mechanisms of this eating disorder are poorly understood, but the classical view defining AN as a purely psychiatric condition is increasingly being challenged. Accumulating evidence from comparative studies of AN and healthy fecal microbial composition reveals considerable low divergence and altered taxonomic abundance of the AN gut microbiome. When integrated with preclinical data, these findings point to a significant role of the gut microbiome in AN pathophysiology, via effects on host energy metabolism, intestinal permeability, immune function, appetite, and behavior. While complex causal relationships between genetic risk factors, dietary patterns and microbiome, and their relevance for AN onset and perpetuation have not been fully elucidated, preliminary clinical studies support the use of microbiome-based interventions such as fecal microbiota transplants and probiotics as adjuvants to standard AN therapies. Future research should aim to move from observational to mechanistic, as dissecting how specific microbial taxa interact with the host to impact the development of AN could help design novel therapeutic approaches that more effectively address the severe comorbidities and high relapse rate of this serious disorder.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Anorexia nervosa and gut microbiome: implications for weight change and novel treatments
    Wei, Yaohui
    Peng, Sufang
    Lian, Cheng
    Kang, Qing
    Chen, Jue
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 16 (04) : 321 - 332
  • [22] Gut microbiome-metabolites axis: A friend or foe to colorectal cancer progression
    Wu, Hao
    Ma, Wenmeng
    Wang, Yiyao
    Wang, Yuanyuan
    Sun, Xun
    Zheng, Qianqian
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 173
  • [23] The causality between gut microbiome and anorexia nervosa: a Mendelian randomization analysis
    Xia, Xuan
    He, Shu-yang
    Zhang, Xiao-Lin
    Wang, Decheng
    He, Qian
    Xiao, Qing-Ao
    Yang, Yong
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [24] The gut microbiota: friend or foe?
    Rachel David
    Nature Reviews Microbiology, 2011, 9 : 831 - 831
  • [25] The Microbiome of the Nose-Friend or Foe?
    Dimitri-Pinheiro, Sofia
    Soares, Raquel
    Barata, Pedro
    ALLERGY & RHINOLOGY, 2020, 11
  • [26] The infant intestinal microbiome: Friend or foe?
    Mshvildadze, Maka
    Neu, Josef
    EARLY HUMAN DEVELOPMENT, 2010, 86 (01) : S67 - S71
  • [27] The reproductive microbiome in dogs: Friend or foe?
    Banchi, Penelope
    Spanoghe, Lotte
    Maes, Dominiek
    Morrell, Jane
    Van Soom, Ann
    VETERINARY JOURNAL, 2024, 304
  • [28] Bulimia nervosa: Friend or foe? The pros and cons of bulimia nervosa
    Serpell, L
    Treasure, J
    INTERNATIONAL JOURNAL OF EATING DISORDERS, 2002, 32 (02) : 164 - 170
  • [29] Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
    Toghi, Mehdi
    Bitarafan, Sara
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2019, 14 (04) : 531 - 533
  • [30] Simvastatin Therapy in Multiple Sclerosis Patients with Respect to Gut Microbiome-Friend or Foe?
    Mehdi Toghi
    Sara Bitarafan
    Journal of Neuroimmune Pharmacology, 2019, 14 : 531 - 533